|
ARID4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.638370E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.583000E-04 |
| Normal-vs-Stage2 |
4.621600E-02 |
| Normal-vs-Stage3 |
1.313960E-01 |
| Normal-vs-Stage4 |
3.890800E-01 |
| Stage1-vs-Stage2 |
6.894800E-01 |
| Stage1-vs-Stage3 |
1.948960E-01 |
| Stage1-vs-Stage4 |
5.079400E-01 |
| Stage2-vs-Stage3 |
5.476000E-01 |
| Stage2-vs-Stage4 |
7.804000E-01 |
| Stage3-vs-Stage4 |
8.953000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.939430E-03 |
| Normal-vs-AfricanAmerican |
6.061900E-03 |
| Normal-vs-Asian |
2.010200E-02 |
| Caucasian-vs-AfricanAmerican |
7.993400E-01 |
| Caucasian-vs-Asian |
5.473800E-01 |
| AfricanAmerican-vs-Asian |
5.503200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.173000E-04 |
| Normal-vs-Female |
5.639200E-01 |
| Male-vs-Female |
1.997800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.554400E-02 |
| Normal-vs-Extreme_Weight |
3.151900E-04 |
| Normal-vs-Obese |
9.914300E-02 |
| Normal-vs-Extreme_Obese |
3.678000E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.245190E-01 |
| Normal_Weight-vs-Obese |
6.547600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.242200E-01 |
| Extreme_Weight-vs-Obese |
2.076200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.494600E-01 |
| Obese-vs-Extreme_Obese |
1.679440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.745400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.184100E-02 |
| Normal-vs-Age(61-80Yrs) |
5.175000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.64529999999919E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.876800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.168400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.283200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.136900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.150700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.548560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.218600E-03 |
| Normal-VS-Type2 PRCC |
1.024140E-03 |
| Normal-VS-KIRP CIMP |
8.906200E-01 |
| Normal-VS-Unclassified PRCC |
2.435400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.574600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.016610E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.304020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.923900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.580100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.706800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85279999997956E-06 |
| Normal-vs-N1 |
7.660800E-01 |
| Normal-vs-N2 |
8.247200E-01 |
| N0-vs-N1 |
6.524900E-03 |
| N0-vs-N2 |
5.223500E-02 |
| N1-vs-N2 |
8.043400E-01 |
|
|
